These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 16243643)

  • 21. Near-infrared optical imaging of epidermal growth factor receptor in breast cancer xenografts.
    Ke S; Wen X; Gurfinkel M; Charnsangavej C; Wallace S; Sevick-Muraca EM; Li C
    Cancer Res; 2003 Nov; 63(22):7870-5. PubMed ID: 14633715
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biodistribution of a nonpeptidic fluorescent endothelin A receptor imaging probe.
    Höltke C; Waldeck J; Kopka K; Heindel W; Schober O; Schäfers M; Bremer C
    Mol Imaging; 2009; 8(1):27-34. PubMed ID: 19344573
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and testing of a binary catalytic system for imaging of signal amplification in vivo.
    Bogdanov A; Kang HW; Querol M; Pretorius PH; Yudina A
    Bioconjug Chem; 2007; 18(4):1123-30. PubMed ID: 17508710
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of [99mTc/EDDA/HYNIC0]octreotide derivatives compared with [111In-DOTA0,Tyr3, Thr8]octreotide and [111In-DTPA0]octreotide: does tumor or pancreas uptake correlate with the rate of internalization?
    Storch D; Béhé M; Walter MA; Chen J; Powell P; Mikolajczak R; Mäcke HR
    J Nucl Med; 2005 Sep; 46(9):1561-9. PubMed ID: 16157541
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantifying molecular specificity of alphavbeta3 integrin-targeted optical contrast agents with dynamic optical imaging.
    Gurfinkel M; Ke S; Wang W; Li C; Sevick-Muraca EM
    J Biomed Opt; 2005; 10(3):034019. PubMed ID: 16229663
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A new high affinity technetium analogue of bombesin containing DTPA as a pharmacokinetic modifier.
    Lin KS; Luu A; Baidoo KE; Hashemzadeh-Gargari H; Chen MK; Pili R; Pomper M; Carducci M; Wagner HN
    Bioconjug Chem; 2004; 15(6):1416-23. PubMed ID: 15546210
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of [(111/114m)In]CHX-A''-DTPA-ZHER2:342, an affibody ligand coniugate for targeting of HER2-expressing malignant tumors.
    Orlova A; Rosik D; Sandström M; Lundqvist H; Einarsson L; Tolmachev V
    Q J Nucl Med Mol Imaging; 2007 Dec; 51(4):314-23. PubMed ID: 17464277
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vivo biodistribution and lifetime analysis of cy5.5-conjugated rituximab in mice bearing lymphoid tumor xenograft using time-domain near-infrared optical imaging.
    Biffi S; Garrovo C; Macor P; Tripodo C; Zorzet S; Secco E; Tedesco F; Lorusso V
    Mol Imaging; 2008; 7(6):272-82. PubMed ID: 19123997
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Feasibility of in vivo multichannel optical imaging of gene expression: experimental study in mice.
    Mahmood U; Tung CH; Tang Y; Weissleder R
    Radiology; 2002 Aug; 224(2):446-51. PubMed ID: 12147841
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of an asialoglycoprotein receptor-targeted magnetic resonance contrast agent to study changes in receptor biology during liver regeneration and endotoxemia in rats.
    Leveille-Webster CR; Rogers J; Arias IM
    Hepatology; 1996 Jun; 23(6):1631-41. PubMed ID: 8675187
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Semiautomatic landmark-based two-dimensional-three-dimensional image fusion in living mice: correlation of near-infrared fluorescence imaging of Cy5.5-labeled antibodies with flat-panel volume computed tomography.
    Dullin C; Zientkowska M; Napp J; Missbach-Guentner J; Krell HW; Müller F; Grabbe E; Tietze LF; Alves F
    Mol Imaging; 2009; 8(1):2-14. PubMed ID: 19344571
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Whole-body fluorescence lifetime imaging of a tumor-targeted near-infrared molecular probe in mice.
    Bloch S; Lesage F; McIntosh L; Gandjbakhche A; Liang K; Achilefu S
    J Biomed Opt; 2005; 10(5):054003. PubMed ID: 16292963
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Noninvasive near-infrared imaging of fluorochromes within the brain of live mice: an in vivo phantom study.
    Klohs J; Steinbrink J; Nierhaus T; Bourayou R; Lindauer U; Bahmani P; Dirnagl U; Wunder A
    Mol Imaging; 2006 Jul; 5(3):180-7. PubMed ID: 16954033
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Near-infrared fluorescence imaging of CD13 receptor expression using a novel Cy5.5-labeled dimeric NGR peptide.
    Li G; Xing Y; Wang J; Conti PS; Chen K
    Amino Acids; 2014 Jun; 46(6):1547-56. PubMed ID: 24652439
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of Gd-DTPA-labeled dextran as an intravascular MR contrast agent: imaging characteristics in normal rat tissues.
    Wang SC; Wikström MG; White DL; Klaveness J; Holtz E; Rongved P; Moseley ME; Brasch RC
    Radiology; 1990 May; 175(2):483-8. PubMed ID: 1691513
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fluorescent 6-amino-6-deoxyglycoconjugates for glucose transporter mediated bioimaging.
    Liu X; Liu S; Liu X; Shi Y; Yang J; Huang Z; Zhao H; Gao Q
    Biochem Biophys Res Commun; 2016 Nov; 480(3):341-347. PubMed ID: 27765631
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vivo and in vitro evaluation of Cy5.5 conjugated epidermal growth factor receptor binding peptide.
    Jeong MH; Kim K; Kim EM; Cheong SJ; Lee CM; Jeong HJ; Kim DW; Lim ST; Sohn MH; Chung J
    Nucl Med Biol; 2012 Aug; 39(6):805-12. PubMed ID: 22421431
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vivo MR/optical imaging for gastrin releasing peptide receptor of prostate cancer tumor using Gd-TTDA-NP-BN-Cy5.5.
    Lin YH; Dayananda K; Chen CY; Liu GC; Luo TY; Hsu HS; Wang YM
    Bioorg Med Chem; 2011 Feb; 19(3):1085-96. PubMed ID: 20493715
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An HDAC-Targeted Imaging Probe LBH589-Cy5.5 for Tumor Detection and Therapy Evaluation.
    Meng Q; Liu Z; Li F; Ma J; Wang H; Huan Y; Li Z
    Mol Pharm; 2015 Jul; 12(7):2469-76. PubMed ID: 26030093
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metal-Chelating Polymers (MCPs) with Zwitterionic Pendant Groups Complexed to Trastuzumab Exhibit Decreased Liver Accumulation Compared to Polyanionic MCP Immunoconjugates.
    Liu P; Boyle AJ; Lu Y; Adams J; Chi Y; Reilly RM; Winnik MA
    Biomacromolecules; 2015 Nov; 16(11):3613-23. PubMed ID: 26469142
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.